Characteristics of Nuclear Cardiology Laboratories Applying for IAC Nuclear/PET Accreditation, 2011–2014
| Characteristic | All laboratories (n = 1,913) | Accreditation granted (n = 779) | Accreditation delayed (n = 1,134) | P |
| Facility characteristics | ||||
| Region (n) | 0.002 | |||
| Northeast | 478 (25.0%) | 203 (26.1%) | 275 (24.3%) | |
| Midwest | 329 (17.2%) | 160 (20.5%) | 169 (14.9%) | |
| South | 869 (45.4%) | 318 (40.8%) | 551 (48.6%) | |
| West | 237 (12.4%) | 98 (12.6%) | 139 (12.3%) | |
| Hospital-based laboratory (n) | 232 (12.1%) | 98 (12.6%) | 134 (11.8%) | 0.62 |
| Number of sites (mean) | 1.72 (SD, 3.21) | 1.79 (SD, 3.68) | 1.68 (SD, 2.84) | 0.21 |
| General nuclear medicine or PET (n) | 175 (9.1%) | 60 (7.7%) | 115 (14.8%) | 0.07 |
| MPI volume (mean) | 1,457.58 (SD, 1,638.33) | 1,549.5 (SD, 1,769.28) | 1,394.5 (SD, 1,539.58) | 0.06 |
| Number of application cycles (mean) | 2.82 (SD, 1.01) | 2.87 (SD, 1.02) | 2.78 (SD, 1.01) | 0.12 |
| Consultant used (n) | 318 (16.6%) | 166 (21.3%) | 152 (13.4%) | <0.001 |